TrialHaematologica2019

Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogs.

Bruno Fattizzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.